Fingerprint
Dive into the research topics of 'Immune checkpoint inhibitor dosing: Can we go lower without compromising clinical efficacy?'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Immune checkpoint inhibitor dosing: Can we go lower without compromising clinical efficacy?
Alex Renner, Mauricio Burotto, Carlos Rojas
Research output: Contribution to journal › Article › peer-review
50
Scopus
citations